未登录
分享
收藏BGB-45035, a selective IRAK4 CDAC, demonstrated fast IRAK4 degradation and strong signaling inhibition, and superior efficacy in preclinical disease modelsBGB-45035是一种选择性IRAK4 CDAC,在临床前疾病模型中显示出快速的IRAK4降解和强的信号抑制作用,以及优异的疗效。
Guo, Hui; Li, Shuran; Yuan, Xi; Sun, Dongqing; Yang, Shasha; Lu, Si; Zhu, Yutong; Yang, Xuefei; Zhang, Shuo; Liu, Wen; Xue, Qianghua; Zheng, Lingmin; Cheng, Zhiling; Qiu, Yang; Liu, Ying; Shao, Bin; Guo, Mingming; Lian, Zeqin; Li, Xin; Jiang, Beibei; Liu, Huaqing; Song, Xiaomin
分享
收藏
分享
收藏
分享
收藏
分享
收藏